Abstract:Botulinum toxin type A (BTX-A) can change the eye alignment system through chemodenervation on extraocular muscles. The breakdown in the balance of eye alignment system which is supported by agonistic and antagonistic muscles, in combination with brain feedback, can stimulates muscle remodeling to reconstruct new binocular vision and restore eye alignment. Since BTX-A was approved by FDA in 1989 for the treatment of strabismus, it has become one of the important non-surgical treatments for strabismus in children. It has the advantages of low invasiveness, short duration of anesthesia and scar-free after treatment. This review will introduce the history, injection methods, and types of BTX-A, as well as its application in the treatment of various types of strabismus in children.

[The role of Botulinum toxin type A in the treatment of childhood strabismus]